Chemocentryx reported $440.45M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbvie ABBV:US $ 143211M 3318M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Amgen AMGN:US $ 59196M 1969M
AstraZeneca AZN:LN 100273M 5090M
Bayer BAYN:GR € 125782M 5541M
Biogen BIIB:US $ 23614.4M 262.9M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Chemocentryx CCXI:US $ 440.45M 14.8M
GlaxoSmithKline GSK:LN 89689M 10586M
Glaxosmithkline GSK:US $ 89689M 10586M
Johnson & Johnson JNJ:US $ 178355M 3663M
Macrogenics MGNX:US $ 271.44M 63.8M
Merk MRK:US $ 106668M 974M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Novartis NOVN:VX SF 125218M 6577M
Omeros OMER:US $ 369.26M 50M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Takeda 4502:JP Y 13178018M 479499M
Teva Pharmaceutical TEVA:IT 47.06B 607M
YTE INCY:US $ 5054.22M 120.87M